{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:27:42Z","timestamp":1762918062141,"version":"build-2065373602"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.mehy.2019.109440","type":"journal-article","created":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T12:06:57Z","timestamp":1571400417000},"page":"109440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["ADAMTS4 and ADAMTS5 may be considered as new molecular therapeutic targets for cartilage damages with Kashin-Beck Disease"],"prefix":"10.1016","volume":"135","author":[{"given":"Peilin","family":"Meng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng'e","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SiJia","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.mehy.2019.109440_b0005","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1023\/A:1020185404126","article-title":"Aging, articular cartilage chondrocyte senescence and osteoarthritis","volume":"3","author":"Martin","year":"2002","journal-title":"Biogerontology"},{"issue":"4","key":"10.1016\/j.mehy.2019.109440_b0010","first-page":"77","article-title":"Proteolytic enzymes and the destruction of articular cartilage in arthritis and chronic polyarthritis","volume":"141","author":"Mohamed-Ali","year":"1991","journal-title":"Wien Med Wochenschr"},{"issue":"2","key":"10.1016\/j.mehy.2019.109440_b0015","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/15287399209531597","article-title":"Study on the pathogenic factors of kashin-beck disease","volume":"35","author":"Peng","year":"1992","journal-title":"J Toxicol Environ Health"},{"issue":"3","key":"10.1016\/j.mehy.2019.109440_b0020","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s002640000179","article-title":"Kashin-Beck disease: from etiology to prevention or from prevention to etiology?","volume":"25","author":"Sudre","year":"2001","journal-title":"Int Orthop"},{"issue":"3","key":"10.1016\/j.mehy.2019.109440_b0025","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s002640100247","article-title":"Epidemiological support for a multifactorial aetiology of Kashin-Beck disease in Tibet","volume":"25","author":"Suetens","year":"2001","journal-title":"Int Orthop"},{"issue":"3","key":"10.1016\/j.mehy.2019.109440_b0030","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s002640100248","article-title":"Diagnostic, clinical and radiological characteristics of Kashin-Beck disease in Shaanxi Province, PR China","volume":"25","author":"Xiong","year":"2001","journal-title":"Int Orthop"},{"issue":"Part 1","key":"10.1016\/j.mehy.2019.109440_b0035","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1042\/bj3330159","article-title":"Membrane type 1 matrix metalloproteinase (MT1-MMP) cleaves the recombinant aggrecan substrate rAgg1mut at the 'aggrecanase' and the MMP sites. Characterization of MT1-MMP catabolic activities on the interglobular domain of aggrecan","volume":"333","author":"B\u00fcttner","year":"1998","journal-title":"Biochem J"},{"issue":"2","key":"10.1016\/j.mehy.2019.109440_b0040","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0021-9258(18)48387-1","article-title":"Identification of a stromelysin cleavage site within the interglobular domain of human aggrecan. Evidence for proteolysis at this site in vivo in human articular cartilage","volume":"267","author":"Flannery","year":"1992","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2019.109440_b0045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0014-5793(95)01539-6","article-title":"Degradation of cartilage aggrecan by collagenase-3 (MMP-13)","volume":"380","author":"Fosang","year":"1996","journal-title":"FEBS Lett"},{"issue":"1","key":"10.1016\/j.mehy.2019.109440_b0050","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1042\/bj2950273","article-title":"Fibroblast and neutrophil collagenases cleave at 2 sites in the cartilage aggrecan interglobular domain","volume":"295","author":"Fosang","year":"1993","journal-title":"Biochem J"},{"issue":"27","key":"10.1016\/j.mehy.2019.109440_b0055","doi-asserted-by":"crossref","first-page":"19470","DOI":"10.1016\/S0021-9258(18)41799-1","article-title":"The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B","volume":"267","author":"Fosang","year":"1992","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.mehy.2019.109440_b0060","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1172\/JCI118357","article-title":"Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration","volume":"96","author":"Hollander","year":"1995","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.mehy.2019.109440_b0065","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2106\/00004623-197052030-00002","article-title":"Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips","volume":"52","author":"Mankin","year":"1970","journal-title":"J Bone Joint Surg Am"},{"issue":"12","key":"10.1016\/j.mehy.2019.109440_b0070","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1093\/rheumatology\/ker230","article-title":"Down-regulated HS6ST2 in osteoarthritis and Kashin-Beck disease inhibits cell viability and influences expression of the genes relevant to aggrecan metabolism of human chondrocytes","volume":"50","author":"Wei","year":"2011","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.mehy.2019.109440_b0075","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/joca.1998.0159","article-title":"Articular cartilage repair: are the intrinsic biological constraints undermining this process insuperable?","volume":"7","author":"Hunziker","year":"1999","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.mehy.2019.109440_b0080","first-page":"pp.11-22","article-title":"Synthesis of an aggrecan mimic for osteoarthritis specific cartilage treatment","volume":"63","author":"Bernhard","year":"2011","journal-title":"Dissertations & Theses - Gradworks"},{"issue":"1","key":"10.1016\/j.mehy.2019.109440_b0085","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/j.joca.2017.02.099","article-title":"A biomarker of aggrecanase degraded aggrecan is associated with key characteristics of OA \u2013 investigation in a phase III clinical study","volume":"25","author":"Siebuhr","year":"2017","journal-title":"Osteoarthritis Cartilage"},{"issue":"12","key":"10.1016\/j.mehy.2019.109440_b0090","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.2174\/138161209787846739","article-title":"Cartilage and bone extracellular matrix","volume":"15","author":"Chiara","year":"2009","journal-title":"Curr Pharm Des"},{"issue":"5","key":"10.1016\/j.mehy.2019.109440_b0095","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00296-008-0744-z","article-title":"Expression of ADAMTS-4 by chondrocytes in the surface zone of human osteoarthritic cartilage is regulated by epigenetic DNA de-methylation","volume":"29","author":"Cheung","year":"2009","journal-title":"Rheumatol Int"},{"issue":"3","key":"10.1016\/j.mehy.2019.109440_b0100","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s11033-009-9495-5","article-title":"Suppression of aggrecanase: a novel protective mechanism of dehydroepiandrosterone in osteoarthritis?","volume":"37","author":"Huang","year":"2010","journal-title":"Mol Biol Rep"},{"issue":"6","key":"10.1016\/j.mehy.2019.109440_b0105","doi-asserted-by":"crossref","first-page":"R230","DOI":"10.1186\/ar3217","article-title":"Association between synovial fluid levels of aggrecan ARGS fragments and radiographic progression in knee osteoarthritis","volume":"12","author":"Larsson","year":"2010","journal-title":"Arthritis Res Therapy"},{"issue":"6","key":"10.1016\/j.mehy.2019.109440_b0110","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1136\/ard.2007.086884","article-title":"Hyaluronan inhibits expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic chondrocytes","volume":"68","author":"Yatabe","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.mehy.2019.109440_b0115","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/art.21022","article-title":"ADAMTS-1-knockout mice do not exhibit abnormalities in aggrecan turnover in vitro or in vivo","volume":"52","author":"Little","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"10.1016\/j.mehy.2019.109440_b0120","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1002\/jcb.23298","article-title":"ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis","volume":"112","author":"Priyanka","year":"2011","journal-title":"J Cell Biochem"},{"issue":"2","key":"10.1016\/j.mehy.2019.109440_b0125","first-page":"575","article-title":"Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5","volume":"56","author":"Ruo-Hua","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"10.1016\/j.mehy.2019.109440_b0130","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1440-1827.2007.02167.x","article-title":"Expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic cartilage","volume":"57","author":"Naito","year":"2010","journal-title":"Pathol Int"},{"issue":"4","key":"10.1016\/j.mehy.2019.109440_b0135","article-title":"The effect of protease inhibitors on the induction of osteoarthritis-related biomarkers in bovine full-depth cartilage explants","volume":"22","author":"He","year":"2014","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.mehy.2019.109440_b0140","article-title":"T-2 Toxin Induces epiphyseal plate lesions via decreased SECISBP2-mediated selenoprotein expression in DA rats, exacerbated by selenium deficiency","author":"Sun","year":"2018","journal-title":"Cartilage"},{"key":"10.1016\/j.mehy.2019.109440_b0145","first-page":"867","article-title":"The role of increased synovial fluid A disintegrin and metalloproteinase with thrombospondin motifs4 and serglycin levels in osteoarthritis","volume":"11","author":"\u00d6zler","year":"2018","journal-title":"Ir J Med Sci"},{"issue":"4","key":"10.1016\/j.mehy.2019.109440_b0150","doi-asserted-by":"crossref","first-page":"9642","DOI":"10.4238\/2014.November.14.9","article-title":"Increased serum ADAMTS-4 in knee osteoarthritis: a potential indicator for the diagnosis of osteoarthritis in early stages","volume":"13","author":"Li","year":"2014","journal-title":"Genetics Mol Res Gmr"},{"issue":"8","key":"10.1016\/j.mehy.2019.109440_b0155","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1002\/art.20558","article-title":"Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice","volume":"50","author":"Glasson","year":"2010","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.mehy.2019.109440_b0160","first-page":"569","article-title":"Expression of ADAMTS4 in Ewing's sarcoma","volume":"37","author":"Minobe","year":"2010","journal-title":"Int J Oncol"},{"issue":"2","key":"10.1016\/j.mehy.2019.109440_b0165","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20188109","article-title":"Genetic variation of aggrecanase-2 (ADAMTS5) in susceptibility to osteoarthritis","volume":"52","author":"Zhou","year":"2019","journal-title":"Braz J Med Biol Res"},{"issue":"1","key":"10.1016\/j.mehy.2019.109440_b0170","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1038\/s41467-019-10177-1","article-title":"Wwp2 maintains cartilage homeostasis through regulation of Adamts5","volume":"10","author":"Mokuda","year":"2019","journal-title":"Nat Commun"},{"issue":"7033","key":"10.1016\/j.mehy.2019.109440_b0175","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/nature03369","article-title":"Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis","volume":"434","author":"Glasson","year":"2005","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.mehy.2019.109440_b0180","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/BRS.0000000000002258","article-title":"ADAMTS5 deficiency protects mice from chronic tobacco smoking-induced intervertebral disc degeneration","volume":"42","author":"Ngo","year":"2017","journal-title":"Spine"},{"issue":"5","key":"10.1016\/j.mehy.2019.109440_b0185","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.joca.2008.09.018","article-title":"ADAMTS5\u2212\/\u2212 mice have less subchondral bone changes after induction of osteoarthritis through surgical instability: implications for a link between cartilage and subchondral bone changes","volume":"17","author":"Botter","year":"2009","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.mehy.2019.109440_b0190","doi-asserted-by":"crossref","unstructured":"Yefu L., Lin X., Advances in understanding cartilage remodeling. 2015. 4:pp. 642.","DOI":"10.12688\/f1000research.6514.1"},{"issue":"12","key":"10.1016\/j.mehy.2019.109440_b0195","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.joca.2015.06.014","article-title":"SOX9 is a regulator of ADAMTSs-induced cartilage degeneration at the early stage of human osteoarthritis","volume":"23","author":"Zhang","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"issue":"11","key":"10.1016\/j.mehy.2019.109440_b0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002580","article-title":"ADAMTS5 is a critical regulator of virus-specific T cell immunity","volume":"14","author":"Mcmahon","year":"2016","journal-title":"PLoS Biol"},{"key":"10.1016\/j.mehy.2019.109440_b0205","unstructured":"Bartnik E., Margerie D., Regulated genes by stimulation of chondrocytes with 1L-1beta. 1996."},{"issue":"7033","key":"10.1016\/j.mehy.2019.109440_b0210","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature03417","article-title":"ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro","volume":"434","author":"Heather","year":"2005","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.mehy.2019.109440_b0215","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/1529-0131(200201)46:1<124::AID-ART10121>3.0.CO;2-X","article-title":"Cyclosporin A inhibition of aggrecanase-mediated proteoglycan catabolism in articular cartilage","volume":"46","author":"Little","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.mehy.2019.109440_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13018-016-0398-6","article-title":"Investigation of MMP-1 genetic polymorphisms and protein expression and their effects on the risk of Kashin-Beck disease in the northwest Chinese Han population","volume":"11","author":"Shi","year":"2016","journal-title":"J Orthopaedic Surg Res"},{"issue":"1","key":"10.1016\/j.mehy.2019.109440_b0225","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/jor.22708","article-title":"Altered proteolytic activity and expression of MMPs and aggrecanases and their inhibitors in Kashin-Beck disease","volume":"33","author":"Jinghong","year":"2015","journal-title":"J Orthopaedic Res"},{"issue":"10","key":"10.1016\/j.mehy.2019.109440_b0230","article-title":"Effects of the mycotoxin nivalenol on bovine articular chondrocyte metabolism in vitro","volume":"9","author":"Siyuan","year":"2014","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.mehy.2019.109440_b0235","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/s13075-014-0429-9","article-title":"Current and emerging therapeutic strategies for preventing inflammation and aggrecanase-mediated cartilage destruction in arthritis","volume":"16","author":"Dancevic","year":"2014","journal-title":"Arthritis Res Therapy"},{"issue":"3","key":"10.1016\/j.mehy.2019.109440_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/S0014-5793(01)02323-7","article-title":"Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4)","volume":"494","author":"Hashimoto","year":"2001","journal-title":"FEBS Lett"},{"issue":"13","key":"10.1016\/j.mehy.2019.109440_b0245","doi-asserted-by":"crossref","first-page":"5933","DOI":"10.1021\/acs.jmedchem.7b00650","article-title":"A highly selective hydantoin inhibitor of aggrecanase-1 and aggrecanase-2 with a low projected human dose","volume":"60","author":"Durham","year":"2017","journal-title":"J Med Chem"},{"issue":"9","key":"10.1016\/j.mehy.2019.109440_b0250","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/nm.1998","article-title":"Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown in osteoarthritis","volume":"15","author":"Echtermeyer","year":"2009","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.mehy.2019.109440_b0255","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00109-016-1418-z","article-title":"The IL-1\u03b2\/AP-1\/miR-30a\/ADAMTS-5 axis regulates cartilage matrix degradation in human osteoarthritis","volume":"94","author":"Ji","year":"2016","journal-title":"J Mol Med"},{"issue":"6","key":"10.1016\/j.mehy.2019.109440_b0260","article-title":"Notice of retraction: \u201cPathologic indicators of degradation and inflammation in human osteoarthritic cartilage are abrogated by exposure to n-3 fatty acids\u201d (Arthritis Rheum 2002;46:1544-53)","volume":"46","author":"Bruce","year":"2002","journal-title":"Arthritis Rheumatism"},{"issue":"31","key":"10.1016\/j.mehy.2019.109440_b0265","doi-asserted-by":"crossref","first-page":"32483","DOI":"10.1074\/jbc.M314216200","article-title":"ADAMTS4 (aggrecanase-1) interaction with the C-terminal domain of fibronectin inhibits proteolysis of aggrecan","volume":"279","author":"Gakuji","year":"2004","journal-title":"J Biol Chem"},{"issue":"24","key":"10.1016\/j.mehy.2019.109440_b0270","doi-asserted-by":"crossref","first-page":"5475","DOI":"10.1242\/dev.127.24.5475","article-title":"Papilin in development; a pericellular protein with a homology to the ADAMTS metalloproteinases","volume":"127","author":"Kramerova","year":"2000","journal-title":"Development"},{"issue":"1","key":"10.1016\/j.mehy.2019.109440_b0275","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1042\/BJ20151072","article-title":"Anti-ADAMTS5 monoclonal antibodies: implications for aggrecanase inhibition in osteoarthritis","volume":"473","author":"Apte","year":"2016","journal-title":"Biochem J"},{"issue":"5","key":"10.1016\/j.mehy.2019.109440_b0280","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.3892\/ijmm.2013.1318","article-title":"Protective effect of lentivirus-mediated siRNA targeting ADAMTS-5 on cartilage degradation in a rat model of osteoarthritis","volume":"31","author":"Xiangyu","year":"2013","journal-title":"Int J Mol Med"},{"issue":"1","key":"10.1016\/j.mehy.2019.109440_b0285","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13075-018-1583-2","article-title":"Upper zone of growth plate and cartilage matrix associated protein protects cartilage during inflammatory arthritis","volume":"20","author":"Seuffert","year":"2018","journal-title":"Arthritis Res Therapy"},{"issue":"3","key":"10.1016\/j.mehy.2019.109440_b0290","first-page":"523","article-title":"Adenoviral gene transfer of the endogenous inhibitor IkappaBalpha into human osteoarthritis synovial fibroblasts demonstrates that several matrix metalloproteinases and aggrecanases are nuclear factor-kappaB-dependent","volume":"34","author":"Bondeson","year":"2007","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.mehy.2019.109440_b0295","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2106\/00004623-197052030-00002","article-title":"Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips","volume":"52","author":"Mankin","year":"1970","journal-title":"J Bone Joint Surg Am"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987719309892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987719309892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:18:10Z","timestamp":1759691890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987719309892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":59,"alternative-id":["S0306987719309892"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2019.109440","relation":{},"ISSN":["0306-9877"],"issn-type":[{"type":"print","value":"0306-9877"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ADAMTS4 and ADAMTS5 may be considered as new molecular therapeutic targets for cartilage damages with Kashin-Beck Disease","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2019.109440","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109440"}}